au.\*:("SPANISH GROUP FOR THE STUDY OF DRUG-INDUCED LIVER DISEASE (GRUPO DE ESTUDIO PARA LAS HEPATOPATIAS ASOCIADAS A MEDICAMENTOS ,GEHAM)")
Results 1 to 4 of 4
Selection :
Evaluation of Naranjo Adverse Drug Reactions Probability Scale in causality assessment of drug-induced liver injuryGARCIA-CORTES, M; LUCENA, M. I; PACHKORIA, K et al.Alimentary pharmacology & therapeutics. 2008, Vol 27, Num 9, pp 780-789, issn 0269-2813, 10 p.Article
Causality assessment methods in drug induced liver injury: Strengths and weaknessesGARCIA-CORTES, Miren; STEPHENS, Camilla; LUCENA, M. Isabel et al.Journal of hepatology. 2011, Vol 55, Num 3, pp 683-691, issn 0168-8278, 9 p.Article
Genetic polymorphisms of CYP2C9 and CYP2C19 are not related to drug-induced idiosyncratic liver injury (DILI)PACHKORIA, K; LUCENA, M. I; RUIZ-CABELLO, F et al.British journal of pharmacology. 2007, Vol 150, Num 6, pp 808-815, issn 0007-1188, 8 p.Article
Determinants of the clinical expression of amoxicillin-clavulanate hepatotoxicity : A prospective series from SpainLUCENA, M. Isabel; ANDRADE, Raul J; BARRIOCANAL, Anabel et al.Hepatology (Baltimore, Md.). 2006, Vol 44, Num 4, pp 850-856, issn 0270-9139, 7 p.Article